Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms
[Posted 09/15/2011] AUDIENCE : Oncology, Anesthesiology ISSUE : FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran (ondansetron, ondansetron hydrochloride and generics). …